Zobrazeno 1 - 10 of 104 pro vyhledávání: '"G. R. Blumenschein"'
1
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
Autor: F. Graf Finckenstein, C. T. Harbison, Everett E. Vokes, Scott J. Antonia, Oscar Arrieta, Enriqueta Felip, Charles M. Rudin, Julie R. Brahmer, Naiyer A. Rizvi, J. Fayette, M. Steins, Neal Ready, L. Crina, Marco Angelo Burgio, C. Dorange, D. R. Spigel, Scott N. Gettinger, Leora Horn, Esther Holgado, F. Barlesi, David E. Gerber, Hossein Borghaei, Luis Paz-Ares, L.Q. Chow, M. Kohlhufl, H. Lena, G. R. Blumenschein, Elena Poddubskaya
Publikováno v: The New England journal of medicine. 373(17)
Nivolumab, a fully human IgG4 programmed death 1 (PD-1) immune-checkpoint-inhibitor antibody, disrupts PD-1-mediated signaling and may restore antitumor immunity.In this randomized, open-label, international phase 3 study, we assigned patients with n
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da5271a999a6066a4ae2ba2399574c63
https://pubmed.ncbi.nlm.nih.gov/29293220
Zobrazit plný text záznamu
2
Multimodality therapy for locally advanced and limited stage IV breast cancer: the impact of effective non-cross-resistance late-consolidation chemotherapy
Autor: G R, Blumenschein, A, DiStefano, J, Caderao, B, Fristenberg, J, Adams, L H, Schweichler, L, Drinkard
Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 3(12 Pt 2)
To determine the effectiveness of non-cross-resistant late-consolidation chemotherapy in locally advanced breast cancer (LABC) and stage IV breast cancer, we review our experience with two regimens. Between 1985 and 1991, we enrolled 56 patients with
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5d0ab4f5c2b5f88ddcd2fe3802662645
https://pubmed.ncbi.nlm.nih.gov/10068266
Zobrazit plný text záznamu
3
Effects of short-term in vivo administration of G-CSF on bone marrow prior to harvesting
Autor: K A, Dicke, D L, Hood, M, Arneson, L, Fulbright, A, DiStefano, B, Firstenberg, J, Adams, G R, Blumenschein
Publikováno v: Experimental hematology. 25(1)
The brief administration of G-CSF to previously treated solid tumor patients has a positive impact on the overall cellularity and progenitor cell content of harvested bone marrow. Fifty-seven patients, fully recovered from therapy and growth factor s
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::87dd306141a088b1a85f70fd8e78985e
https://pubmed.ncbi.nlm.nih.gov/8989904
Zobrazit plný text záznamu
6
Diabetes insipidus and breast cancer
Autor: H Y, Yap, C K, Tashima, G R, Blumenschein, N, Eckles
Publikováno v: Archives of internal medicine. 139(9)
Diabetes insipidus, resulting from metastatic involvement of the neurohypophysial system, is a rare complication of breast cancer. This review examined the clinical features, metastatic pattern, and radiological and postmortem findings of 39 breast c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c208edd5083c360faea3d0e65babccf8
https://pubmed.ncbi.nlm.nih.gov/475518
Zobrazit plný text záznamu
7
Vindesine in the treatment of refractory breast cancer: improvement in therapeutic index with continuous 5-day infusion
Autor: H Y, Yap, G R, Blumenschein, G P, Bodey, G N, Hortobagyi, A U, Buzdar, A, DiStefano
Publikováno v: Cancer treatment reports. 65(9-10)
Sixty patients with metastatic breast cancer refractory to prior doxorubicin combinations were randomized by performance status, dominant disease site, and number of involved organ sites to receive vindesine either as a bolus injection of 3-4 mg/m2 i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5c26f5fccea2ef83d9847c14ae23a24c
https://pubmed.ncbi.nlm.nih.gov/7273012
Zobrazit plný text záznamu
8
Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer. A prospective randomized trial
Autor: A U, Buzdar, G R, Blumenschein, T L, Smith, K C, Powell, G N, Hortobagyi, H Y, Yap, F C, Schell, B C, Barnes, F C, Ames, R G, Martin
Publikováno v: Cancer. 53(3)
Between May 1977 and April 1980, 238 patients with operable breast cancer were treated with adjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) chemotherapy. All patients were randomized to receive FAC alone or FAC with nonspecific immunot
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fb1144a1fe76590d66736ca6aded276b
https://pubmed.ncbi.nlm.nih.gov/6362814
Zobrazit plný text záznamu
10
Immunotherapy of breast cancer, malignant melanoma, and acute leukemia with BCG: Prolongation of disease free interval and survival
Autor: G. R. Blumenschein, Giora M. Mavligit, Evan M. Hersh, Gerald P. Bodey, Ch. M. McBride, Jordan U. Gutterman, J. A. Gottlieb, V. Rodriguez, J. O. Cardenas, M. A. Burgess, Kenneth B. McCredie, Emil J. Freireich
Publikováno v: Cancer Immunology Immunotherapy.
Results of immunotherapy with BCG in patients with malignant melanoma, breast cancer, and acute leukemia are described. The first study demonstrated that high doses of living BCG organisms (6×108 viable units) delivered by scarification in the upper
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b638756ef0291f426a07c0f7857cbac0
https://doi.org/10.1007/bf00205301
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje